Biotech Funding
Selective Capital, Stronger Science: The Emerging Biotech Funding Model
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-25-NI-04Jan 6, 2026
M&A
How are capital constraints impacting M&A and strategic partnerships in the CDMO and pharma sectors?
Pharma's Almanac
PAO-01-26-RT-02Jan 5, 2026
Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
Nice Insight
PAO-04-24-NI-01Apr 2, 2024
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12Jun 24, 2022
Column: M&A
Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game
Nigel Walker
Nice Insight
PAO-03-022-NI-08Mar 23, 2022